Eli Lilly and Company has announced a significant research collaboration and licensing agreement with Ascidian Therapeutics, a pioneering biotechnology firm…
Read More
Breakthrough Research Unveils How Gene Fusion Condensates Drive Rare Kidney Cancer Progression and Offers New Therapeutic Pathways
In a significant advancement for the field of oncology, a collaborative study led by investigators at the Johns Hopkins Kimmel…
Read More
Johns Hopkins Researchers Uncover Liquid Condensate Mechanism Driving Rare Translocation Kidney Cancer and Propose New Therapeutic Avenues
In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
Breakthrough Research Unveils How Gene Fusion Condensates Drive Rare Kidney Cancer Progression and Potential Treatment Pathways
Investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health have identified a…
Read More
Johns Hopkins Researchers Uncover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression
In a significant advancement for the field of oncology and molecular biology, investigators at the Johns Hopkins Kimmel Cancer Center…
Read More
Johns Hopkins Researchers Uncover How Fusion Gene Condensates Drive Rare Kidney Cancer Progression and Propose New Therapeutic Pathways
In a significant advancement for oncology and molecular biology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel Cancer…
Read More
Johns Hopkins Study Reveals How Liquid Droplets Formed by Fusion Genes Drive Rare Kidney Cancer Progression
In a significant advancement for molecular oncology, investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg…
Read More
Johns Hopkins Researchers Discover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression
In a landmark study published in the journal Cell Reports on April 22, investigators at the Johns Hopkins Kimmel Cancer…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Driven by Fusion Gene Liquid Droplets
In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…
Read More
Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Progression via Liquid Condensates
In a significant advancement for the field of molecular oncology, a collaborative study led by investigators at the Johns Hopkins…
Read More
